Steep Hill Plans Medical Cannabis Quality Assurance Laboratory In Albuquerque, New Mexico
02/27/2015
According to the firm, Steep Hill is currently the only laboratory licensed by the New Mexico Department of Health to conduct potency and contaminant testing in order to meet the recently adopted regulatory requirements pertaining to cannabis safety for medical patients in New Mexico.
"We are excited to bring our entire suite of products to New Mexico, including our QuantaCann2, an advanced cloud-based potency monitoring system. This will enable the state to meet its THC and CBD testing requirements, while also providing regulators with a real time window into the marketplace," said David Lampach, CEO/Co-Founder of Steep Hill.
The State of New Mexico requires regular testing be done in a Department of Health approved laboratory as the only acceptable method to determine the quality, purity and potency required for the sale of medical cannabis products.
Founded in Oakland, California, in 2008, Steep Hill is a science and technology firm that has become the industry leader in cannabis testing and analytics in the US and abroad. Steep Hill moved its U.S. headquarters to a larger facility in Berkeley, California, in January 2015.
Project Announcements
Interstate Group Expands Giles County, Virginia, Production Operations
03/11/2026
Shinhwa Auto USA Expands Auburn, Alabama, Operations
03/11/2026
General Atomics Expands Shannon, Mississippi, Production Operations
03/11/2026
Starbucks Plans Davidson County, Tennessee, Corporate Operations
03/08/2026
Canada-Based Dainty Foods Plans Batavia Township, Ohio, Manufacturing Operations
03/08/2026
AeroVironment Expands Albuquerque, New Mexico, Manufacturing Operations
03/08/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
The New Industrial Revolution in Biotech
Q4 2025
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025